Ocular Therapeutix, Inc.
OCUL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$69 | -$68 | -$64 | -$48 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $10 | $10 | $7 |
| Change in WC | $4 | $1 | $6 | $1 |
| Other Non-Cash | $14 | $1 | $2 | -$0 |
| Operating Cash Flow | -$51 | -$55 | -$45 | -$39 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$6 | -$1 | -$2 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$6 | -$1 | -$2 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $10 | $98 | $0 | $1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $4 | $4 |
| Financing Cash Flow | $10 | $98 | $4 | $5 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$46 | $41 | -$42 | -$35 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $391 | $351 | $394 | $429 |
| End Cash | $345 | $393 | $351 | $394 |
| Free Cash Flow | -$57 | -$56 | -$47 | -$40 |